ABSTRACT
In this work investigation of the normoxic PAGAT polymer gel dosimeter such as sensitivity, the R2-dose response with post time and the percentage depth dose [PDD] of PAGAT polymer gel dosimeter have been undertaken. Using MRI, the formulation to give the maximum change in the transverse relaxation rate R2 was determined to be 4.5% N,N'-methylenbis- acrylamide [C][bis], 4.5% acrylamid[AA], 5% gelatin, 5 mM tetrakis [hydroxymethyl]phosphonium chloride [THPC], 0.01 mM hydroquinone [HQ] and 86% HPLC [Water]. Irradiation of vials was performed using photon beams by Co-60 therapy unit and an Electa linear accelerator. Gel dosimeters were imaged in a Siemens Symphony 1.5 Tesla clinical MRI scanner using a head coil. Gel dosimeters were irradiated 1 day post-manufacture, and imaged 1 day post irradiation. The R2- dose response was linear up to 30 Gy. The response of the PAGAT gel is very similar in the lower dose region and the R2-dose response for doses less than 2 Gy is not exact. The R2-dose response of the PAGAT polymer gel dosimeters varies between 10 to 30 Gy with R2-dose sensitivities of 0.0905, 0.1037, 0.1023, 0.0907 and 0.123 S-1Gy-1 when imaged at 1, 8, 15, 29 and 38 days post-irradiation respectively. The percentage depth dose [PDD] of PAGAT gel dosimeter was determined and at depth of 21cm, the percentage depth dose for 1.25, 4, 6 and 18 MV photons were determined to be, 48%, 52%, 57.3% and 59.73% respectively. Calibration curve of the PAGAT polymer gel dosimeter, were found to be linear between 2-10 Gy and 10-30 Gy with different slopes of the R2-dose sensitivity also showed stability with post time imaging after 38 days. In this study, the percentage depth dose [PDD] of the PAGAT gel dosimeter was measured. It can be concluded that in case of higher energy of photon beams, higher doses can be delivered to deep-seated tumors